- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Combined Effect of Not Expanding Medicaid and Losing Marketplace Assistance
As of April 2015, 21 states have chosen not to expand Medicaid eligibility under the Affordable Care Act. All but one of those states have also chosen to rely on federally facilitated marketplaces.
As of April 2015, 21 states have chosen not to expand Medicaid eligibility under the Affordable Care Act. All but one of those states have also chosen to rely on federally facilitated marketplaces.
If the Supreme Court finds for the plaintiff in King v. Burwell, the combined effect of not expanding Medicaid and losing federal support for marketplace coverage for the low-income population would be dramatic for the 20 states affected by both decisions.
In total, 9.8 million people would be uninsured who would have otherwise been insured. Assuming that marketplace financial assistance is not replaced and assuming those states do not choose to expand Medicaid, the total loss in federal spending from 2016 to 2025 would be $721 billion.
Read the full brief at the Urban Institute: http://urbn.is/1Jhwe0X
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
